Atul Dandekar sold $2.9M of Maze Therapeutics (MAZE)

Executed Dec 29 2025, disclosed Dec 31 2025, 2 days later.

Value, as filed

$2.9M

72,400 sh across 2 lots

Executed

Dec 29 2025

the trade date, as filed

Disclosed

Dec 31 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Atul Dandekar CSBO profile →

Atul Dandekar (CSBO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $2.9M of MAZE (72,400 sh across 2 lots, as filed), executed Dec 29 2025.

The name

MAZE

Maze Therapeutics, Inc. MAZE · Healthcare · 36 filings in 24 months ticker →

Healthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Atul Dandekar in MAZE

MAZESALE Maze Therapeutics, Inc. $207K
7,500 sh × $27.58
Exec Aug 28
Filed Aug 31 · 6:32 PM ET MAZESALE Maze Therapeutics, Inc. $194K
7,100 sh × $27.31
Exec Jul 29
Filed Jul 31 · 4:15 PM ET MAZESALE Maze Therapeutics, Inc. $210K
7,500 sh × $28.02
Exec Jun 29
Filed Jul 1 · 4:17 PM ET MAZESALE Maze Therapeutics, Inc. $198K
7,500 sh × $26.34
Exec May 29
Filed Jun 2 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $190K
7,500 sh × $25.37
Exec Apr 29
Filed May 1 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $196K
6,710 sh × $29.26
Exec Mar 30
Filed Apr 1 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $341K
7,500 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $280K
6,300 sh across 2 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET